Bhagawati Oxygen (509449)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹45.71 |
| Market Cap | ₹10.57 Cr |
| P/E Ratio | 67.64 |
| ROCE | -6.68% |
| ROE | 3.6% |
| Dividend Yield | 0% |
| Profit Growth | 61.9% |
| Debt/Equity | — |
| Sales Growth | -80.77% |
| 52-Week Range | ₹32.1 — ₹47.7 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹18.21 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let me start with the obvious: when I see a company whose latest quarter reports ₹0 Cr in sales and ₹-0 Cr in net profit, I don't see an operating business; I see a shell waiting to explain itself. Bhagawati Oxygen is in commodity chemicals, a field where you need scale to survive. Here sales have fallen 80.77%, and return on capital employed is -6.68%. That means the capital inside this business is destroying value, not creating it. The reported profit growth of 61.90% and a positive ROE of 3.60% are misleading because they come from a very small earnings base. A P/E of 67.64 and a PEG of 1.09 are not meaningful when the latest quarter has no revenue. At ₹45.71, I am paying 2.51 times book value of ₹18.21 for a business with no dividend, no meaningful earnings power, and no disclosed promoter holding. The Piotroski score of 5/9 at least suggests not everything is deteriorating, but that is hardly a reason to invest. In the Graham tradition, I need margin of safety. I see price above book, negative ROCE, collapsing sales, and insufficient data. This might be a turnaround candidate someday, but I do not invest based on hope. I need visible sales recovery, positive operating returns, and honest management. Without those, this stays in the too-hard pile.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer